15 October 2020
ACSS Consortium welcomes the U.K. as its newest member
The Medicines and Healthcare products Regulatory Authority (MHRA) is the therapeutic products regulator of the United Kingdom. MHRA will join Australia-Canada-Singapore-Switzerland (ACSS) Consortium as a full member from 1 January 2021. To accommodate the new partner, the group changed its name from ACSS Consortium to Access Consortium.
For further information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
Swissmedic: Revision of the Guidance document Authorisation Biosimilar